Nyumbani › Scleroderma › Texas › Houston
Majaribio ya kliniki ya Scleroderma katika Houston, TX
Masomo 9 ya Scleroderma yanatafuta washiriki katika vituo vya Houston na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
InaajiriHatua 3
- The University of Texas Health Science Center at Houston, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
InaajiriHatua 1
- UT MD Anderson Cancer Center, Houston
Platform Clinical Study for Conquering Scleroderma
InaajiriHatua 2
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
InaajiriHatua 1/2
- Nkarta Investigational Site, Houston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
InaajiriHatua 2
- Artiva Investigational Site Bellaire, Bellaire · Mi 7 mbali
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
InaajiriHatua 2
- The University of Texas Health Science Center at Houston, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
InaajiriHatua 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
Inaajiri
- The University of Texas Health Science Center at Houston, Houston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
InaajiriHatua 2
- aTyr Investigative Site, Houston
Majaribio ya Scleroderma katika miji mingine
- New York City, NYUtafiti 11
- Ann Arbor, MIUtafiti 10
- Chicago, ILUtafiti 10
- Boston, MAUtafiti 7
- Durham, NCUtafiti 7
- Los Angeles, CAUtafiti 7
- New Orleans, LAUtafiti 6
- Baltimore, MDUtafiti 6
- Philadelphia, PAUtafiti 6
- Dallas, TXUtafiti 5
- Pittsburgh, PAUtafiti 5
- Plantation, FLUtafiti 4
Masomo mengine katika Houston
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 145
- Saratani ya MatitiUtafiti 126
- Saratani (aina zote)Utafiti 121
- Saratani ya MetastasiUtafiti 104
- Kansari ya kolorektaliUtafiti 102
- Kansari ya MayaiUtafiti 89
- Leukemia ya Myeloid ya GhaflaUtafiti 85
- Saratan ya MapafuUtafiti 78
- Saratani ya ProstateUtafiti 76
- Saratani ya EndometrialUtafiti 68
- Kansari ya PancreasUtafiti 61
- MelanomaUtafiti 59
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.